Corey Davis
Stock Analyst at HC Wainwright & Co.
(2.53)
# 2,068
Out of 4,829 analysts
17
Total ratings
64.29%
Success rate
9.17%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Corey Davis
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NKTR Nektar Therapeutics | Reiterates: Neutral | $32 → $26 | $0.59 | +4,316.51% | 5 | May 12, 2020 | |
| SCYX SCYNEXIS | Assumes: Buy | $50 | $0.94 | +5,207.86% | 3 | May 7, 2018 | |
| VTVT vTv Therapeutics | Downgrades: Neutral | $560 → $40 | $20.80 | +92.31% | 2 | Apr 10, 2018 | |
| LPCN Lipocine | Initiates: Buy | $170 | $3.24 | +5,146.91% | 1 | Mar 29, 2018 | |
| VNDA Vanda Pharmaceuticals | Initiates: Buy | $20 | $3.95 | +406.33% | 2 | Jan 19, 2018 | |
| PCRX Pacira BioSciences | Initiates: Buy | $50 | $25.12 | +99.04% | 3 | Jan 19, 2018 | |
| JAZZ Jazz Pharmaceuticals | Initiates: Neutral | $144 | $97.78 | +47.27% | 1 | Aug 25, 2017 |
Nektar Therapeutics
May 12, 2020
Reiterates: Neutral
Price Target: $32 → $26
Current: $0.59
Upside: +4,316.51%
SCYNEXIS
May 7, 2018
Assumes: Buy
Price Target: $50
Current: $0.94
Upside: +5,207.86%
vTv Therapeutics
Apr 10, 2018
Downgrades: Neutral
Price Target: $560 → $40
Current: $20.80
Upside: +92.31%
Lipocine
Mar 29, 2018
Initiates: Buy
Price Target: $170
Current: $3.24
Upside: +5,146.91%
Vanda Pharmaceuticals
Jan 19, 2018
Initiates: Buy
Price Target: $20
Current: $3.95
Upside: +406.33%
Pacira BioSciences
Jan 19, 2018
Initiates: Buy
Price Target: $50
Current: $25.12
Upside: +99.04%
Jazz Pharmaceuticals
Aug 25, 2017
Initiates: Neutral
Price Target: $144
Current: $97.78
Upside: +47.27%